报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2024-09-30 | 0.35% | -91.38% | 288.89% | 106/129 | 4.79% | 迈瑞医疗 | 28.68% | 行业排名> |
2024-06-30 | 0.09% | -95.67% | -82% | 96/129 | 3.05% | 迈瑞医疗 | 20.2% | 行业排名> |
2024-03-31 | 0.5% | -66.22% | -74.23% | 88/129 | 1.68% | 迈瑞医疗 | 9.12% | 行业排名> |
2023-12-31 | 1.94% | -68.71% | -52.22% | 92/129 | 5.06% | 迈瑞医疗 | 33.21% | 行业排名> |
2023-09-30 | 4.06% | -20.39% | 95.19% | 72/129 | 5.79% | 迈瑞医疗 | 28.34% | 行业排名> |
2023-06-30 | 2.08% | -6.73% | 40.54% | 82/129 | 3.8% | 迈瑞医疗 | 18.36% | 行业排名> |
2023-03-31 | 1.48% | 40.95% | -76.13% | 74/129 | 2.29% | 安杰思 | 8.56% | 行业排名> |
2022-12-31 | 6.2% | -55.3% | 21.57% | 86/129 | 13.44% | 九安医疗 | 146.56% | 行业排名> |
2022-09-30 | 5.1% | -59.2% | 128.7% | 84/129 | 12.77% | 九安医疗 | 140.94% | 行业排名> |
2022-06-30 | 2.23% | -60.6% | 112.38% | 92/129 | 9.3% | 九安医疗 | 142.25% | 行业排名> |
2022-03-31 | 1.05% | -43.85% | -92.43% | 85/129 | 6.26% | 九安医疗 | 142.71% | 行业排名> |
2021-12-31 | 13.87% | -2.73% | 10.96% | 62/129 | 17.49% | 热景生物 | 121.78% | 行业排名> |
2021-09-30 | 12.5% | 2% | 120.85% | 47/129 | 15.94% | 热景生物 | 99.69% | 行业排名> |
2021-06-30 | 5.66% | 332.06% | 202.67% | 75/129 | 11.54% | 热景生物 | 99.09% | 行业排名> |
2021-03-31 | 1.87% | 2% | -86.89% | 78/129 | 6.23% | 热景生物 | 57.63% | 行业排名> |
2020-12-31 | 14.26% | 25.53% | 988.55% | 67/129 | 25.82% | 中红医疗 | 168% | 行业排名> |
2020-06-30 | 1.31% | 2% | -88.47% | 98/129 | 15.16% | 圣湘生物 | 112.46% | 行业排名> |
2019-12-31 | 11.36% | -0.87% | -0.87% | 71/129 | 14.38% | 博拓生物 | 108.13% | 行业排名> |
2018-12-31 | 11.46% | -17.97% | -17.97% | 63/129 | 12.98% | 圣湘生物 | 29.33% | 行业排名> |
2017-12-31 | 13.97% | 2% | 2% | 48/129 | 13.82% | 健尔康 | 84.09% | 行业排名> |